PetVivo Holdings Inc (PetVivo Holdings) is a biomedical device company. It offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. PetVivo Holdings’ products are used in the treatment of osteoarthritis in equine and canine and are designed to prevent the occurrence and re-occurrence of joint pain from loss of cartilage and tissue-bone mechanical malfunction caused by joint dysfunction such as lameness and osteoarthritis. The company provides its products through its distributors located across the US. PetVivo Holdings is headquartered in Minneapolis, Minnesota, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company PetVivo Holdings Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
PetVivo Holdings Inc Company Overview
PetVivo Holdings Inc Company Snapshot
PetVivo Holdings Inc Pipeline Products and Ongoing Clinical Trials Overview
PetVivo Holdings Inc – Pipeline Analysis Overview
PetVivo Holdings Inc - Key Facts
PetVivo Holdings Inc - Major Products and Services
PetVivo Holdings Inc Pipeline Products by Development Stage
Mucoadhesive Fentanyl Drug Delivery System Product Overview
OrthoGelic
OrthoGelic Product Overview
OrthoMetic
OrthoMetic Product Overview
Osteoarthritis Device
Osteoarthritis Device Product Overview
Peripheral Vascular Graft
Peripheral Vascular Graft Product Overview
Spinal Disc Repair Device
Spinal Disc Repair Device Product Overview
Vasculitus Wound Closure Device
Vasculitus Wound Closure Device Product Overview
VasoGraft
VasoGraft Product Overview
PetVivo Holdings Inc - Key Competitors
PetVivo Holdings Inc - Key Employees
PetVivo Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
PetVivo Holdings Inc, Recent Developments
Nov 14, 2023: PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
Nov 09, 2023: Petvivo Holdings to Announce Results for the Second Quarter Ended September 30, 2023
Aug 10, 2023: PetVivo Reports First Quarter of Fiscal 2024 Financial Results
Jun 26, 2023: Petvivo Holdings to Announce Results for the Year 2023 Ended March 31, 2023
May 17, 2023: Trina Lally Joins PetVivo Holdings as the Northeast Business Development Manager
Mar 17, 2023: Clinical study results involving Spryng, a PetVivo Holdings, product, presented at the Veterinary Orthopedic Society Annual Conference in Big Sky, Montana
Jan 23, 2023: PetVivo Holdings to Exhibit at the 44th Lake Tahoe Equine Conference in Incline Village, Nevada
Jan 17, 2023: Petvivo Holdings to exhibit at the 2023 Ocala Equine Conference In Ocala, Florida
Oct 20, 2022: PetVivo Holdings to Present at LD Micro Main Event XV
Aug 11, 2022: PetVivo Reports First Quarter of Fiscal 2023 Financial Results